BTT-3033 (oral administration, 10 mg/kg, at 24 h and 2 h before PAF induction) shows anti-inflammatory effects in mouse air pouch model[2].
BTT-3033 (oral administration, 10 mg/kg, at 48 ,24 and 2 h before ear swelling) shows anti-inflammatory effects in arachidonic acid-induced ear edema model[2].
| Animal Model: | PAF (platelet-activating factor)-induced mouse air pouch model[2] |
| Dosage: | 1, 10 mg/kg at 24 h and 2 h before PAF induction |
| Administration: | Oral administration |
| Result: | Reduced the infiltration of leukocytes by about 50% at 10 mg/kg. |
| Animal Model: | Male DBA/1 mice (Pharmacokinetic assay)[2] |
| Dosage: | 10 mg/kg for a single dose |
| Administration: | Oral administration |
| Result: | Plasma levels: about 1 ng/mL at 24 h post-dose. |